R R

What Is Ocular Melanocytosis?

Ocular melanocytosis is a congenital condition in which excess melanocytes are present in the uvea, sclera, and sometimes surrounding tissues of one eye. It often appears as slate gray or blue scleral discoloration and increased fundus pigmentation. The condition is usually unilateral and nonprogressive. People with ocular melanocytosis have a higher lifetime risk of uveal melanoma and can be more prone to glaucoma. Lifelong observation is recommended even when vision is normal.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Ocular Melanocytosis?

Ocular melanocytosis is a congenital condition in which excess melanocytes are present in the uvea, sclera, and sometimes surrounding tissues of one eye. It often appears as slate gray or blue scleral discoloration and increased fundus pigmentation. The condition is usually unilateral and nonprogressive. People with ocular melanocytosis have a higher lifetime risk of uveal melanoma and can be more prone to glaucoma. Lifelong observation is recommended even when vision is normal.

read more about ocular melanocytosis ...

Copy this HTML:

Copy HTML Copied!

Clinical Appearance and Variants

On external exam, ocular melanocytosis can show patchy bluish or gray scleral areas, often in the periocular region. The iris and choroid can appear darker than in the fellow eye, and the fundus may have a more heavily pigmented appearance. When pigmentation extends to periocular skin, the term oculodermal melanocytosis or nevus of Ota is used. Intraocular pressure and angles can look normal early in life. Both subtle and extensive patterns occur along a spectrum.

Associated Risks and Complications

The main ocular concerns are uveal melanoma and glaucoma. Increased melanocyte density in the uvea appears to predispose to malignant transformation, especially in the affected eye. Glaucoma can develop from pigment buildup in the trabecular meshwork or structural angle changes. Rarely, leptomeningeal melanocytosis or melanoma elsewhere in the nervous system can appear in people with widespread pigment involvement. Because of these risks, periodic detailed eye examinations are important.

Diagnosis and Monitoring

Diagnosis is clinical and based on characteristic pigmentation patterns and laterality. Slit lamp and dilated fundus examination document iris, scleral, and choroidal changes. Gonioscopy and intraocular pressure measurements help detect early angle or pressure changes. Baseline photography and, when indicated, ultrasonography of suspicious uveal lesions are obtained. Follow up intervals are tailored to age and findings but usually continue throughout life.

Management and Counseling

There is no way to remove the underlying pigment burden, so management focuses on surveillance and early detection of complications. Regular monitoring for uveal melanoma includes careful fundus exams and targeted imaging of any suspicious lesions. Glaucoma screening is part of each visit, and pressure lowering treatment is started when needed. Counseling discussions explain the slightly higher cancer risk and the value of long term follow up. People are encouraged to seek review for new visual symptoms, pain, or noticeable change in pigmentation.

FAQs About Ocular Melanocytosis

Is ocular melanocytosis the same as heterochromia?

No, heterochromia refers to different iris colors, while ocular melanocytosis involves deeper pigment changes in sclera and uvea and carries different risks.

Can ocular melanocytosis affect both eyes?

Most cases are unilateral. Bilateral involvement is uncommon and often linked to more extensive pigment conditions that need careful assessment.

Does ocular melanocytosis always lead to melanoma?

No, many people never develop cancer, but risk is higher than in the general population, so regular eye exams are advised.

Should family members of someone with ocular melanocytosis be screened?

Routine family screening is not usually required, but relatives who notice similar pigment changes should have a baseline ophthalmic exam.

References

EyeWiki (AAO). ?Oculodermal Melanocytosis (Nevus of Ota).? https://eyewiki.org/Oculodermal_Melanocytosis_%28Nevus_of_Ota%29

University of Iowa, EyeRounds.org. ?Atlas Entry ? Ocular Melanocytosis.? https://webeye.ophth.uiowa.edu/eyeforum/atlas/pages/Ocular-Melanocytosis/index.htm

NCBI Bookshelf (StatPearls). ?Nevus of Ota and Ito.? https://www.ncbi.nlm.nih.gov/books/NBK560574/

JAMA Ophthalmology. ?Ocular Findings in Oculodermal Melanocytosis.? https://jamanetwork.com/journals/jamaophthalmology/fullarticle/638615

JAMA Ophthalmology. ?Association of Ocular and Oculodermal Melanocytosis With Uveal Melanoma Metastasis.? https://jamanetwork.com/journals/jamaophthalmology/fullarticle/1687776